The Possible Role of the Microbiota-Gut-Brain-Axis in Autism Spectrum Disorder
Open accessThe DOI matches its Crossref record; 137 of the 137 references it cites were found in a registry or an index.
Abstract
New research points to a possible link between autism spectrum disorder (ASD) and the gut microbiota as many autistic children have co-occurring gastrointestinal problems. This review focuses on specific alterations of gut microbiota mostly observed in autistic patients. Particularly, the mechanisms through which such alterations may trigger the production of the bacterial metabolites, or leaky gut in autistic people are described. Various altered metabolite levels were observed in the blood and urine of autistic children, many of which were of bacterial origin such as short chain fatty acids (SCFAs), indoles and lipopolysaccharides (LPS). A less integrative gut-blood-barrier is abundant in autistic individuals. This explains the leakage of bacterial metabolites into the patients, triggering new body responses or an altered metabolism. Some other co-occurring symptoms such as mitochondrial dysfunction, oxidative stress in cells, altered tight junctions in the blood-brain barrier and structural changes in the cortex, hippocampus, amygdala and cerebellum were also detected. Moreover, this paper suggests that ASD is associated with an unbalanced gut microbiota (dysbiosis). Although the cause-effect relationship between ASD and gut microbiota is not yet well established, the consumption of specific probiotics may represent a side-effect free tool to re-establish gut homeostasis and promote gut health. The diagnostic and therapeutic value of bacterial-derived compounds as new possible biomarkers, associated with perturbation in the phenylalanine metabolism, as well as potential therapeutic strategies will be discussed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
![Figure 1 Methodical approach of this systematic review due to PRISMA criteria [39].](https://figures.cochat.ai/paper-figures/995f3e7c1bdb4e7fa5d481ab1b14c477/the-possible-role-of-the-microbiota-gut-brain-axis-in-autism-spectrum-disorder-figure-1.jpg)


![Figure 4 Process of Clostridium tetani infection in the gut. Occurrence of the bacterium Clostridium tetani in the GI tract of autistic population could lead to altered behaviour. [43].](https://figures.cochat.ai/paper-figures/43898fd3bd604a37b876bb8b1235dffb/the-possible-role-of-the-microbiota-gut-brain-axis-in-autism-spectrum-disorder-figure-4.jpg)
![Figure 5 Metabolic pathways of tryptophan. The purple pathways show human metabolism of tryptophan and the orange pathways are observed in bacterial degradation. Green surrounded boxes show elevated metabolites and red surrounded boxes show decreased metabolites in the autistic metabolome [101].](https://figures.cochat.ai/paper-figures/cbe7bd9ad387486b9f15801bc57a30b3/the-possible-role-of-the-microbiota-gut-brain-axis-in-autism-spectrum-disorder-figure-5.jpg)
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Increased BBB permeability has been associated with heightened microglial activity and a reduction in astrocyte numbers and functionality [52,76].”
From The Gut–Brain–Microbiota Connection and Its Role in Autism Spectrum Disorders (2025) · cites this paper as [52]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Studies has shown a significant increase in the prevalence of Clostridium bacteria in ASD patients compared to the general population [8,50,52,96,97,98,99,100,101,102,103,104,105,106,107,108,109].”
From The Gut–Brain–Microbiota Connection and Its Role in Autism Spectrum Disorders (2025) · cites this paper as [52]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“A notable decrease in the prevalence of bacteria from the Veillonellaceae and Streptococcaceae families was observed in patients with ASD.”
From The Gut–Brain–Microbiota Connection and Its Role in Autism Spectrum Disorders (2025) · cites this paper as [52]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“It was also observed that the abundance of the genus Faecalibacterium, particularly the Faecalibacterium prausnitzii species, should be lower in healthy individuals compared to patients diagnosed with ASD [52,89,101,107,109,113].”
From The Gut–Brain–Microbiota Connection and Its Role in Autism Spectrum Disorders (2025) · cites this paper as [52]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In addition, the presence of Staphylococcus, Coprococcus, Lactococcus, and Flavonifractor may be detected in lower quantities [8,52,107,111,114,115].”
From The Gut–Brain–Microbiota Connection and Its Role in Autism Spectrum Disorders (2025) · cites this paper as [52]
Experimental — accuracy not yet measured
25 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & for the PRISMA Group (2009) · BMJ · doi:10.1136/bmj.b2535 · Cited by 83,823
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & The PRISMA Group (2009) · PLoS Medicine · doi:10.1371/journal.pmed.1000097 · Cited by 64,042 · cited 2×
“ethodical approach of this systematic review due to PRISMA criteria [39].”
Wang, G., Ma, R., Qiao, G., Wada, K., Aizawa, Y., & Satoh, T. (2015) · Integrative Medicine International · doi:10.1159/000368408 · Cited by 18,657
Baio, J., Wiggins, L., Christensen, D. L., Maenner, M. J., Daniels, J., Warren, Z., Kurzius-Spencer, M., Zahorodny, W., Robinson, C., Rosenberg, et al. (2018) · MMWR. Surveillance Summaries · doi:10.15585/mmwr.ss6706a1 · Cited by 6,078
Hsiao, E. Y., McBride, S. W., Hsien, S., Sharon, G., Hyde, E. R., McCue, T., Codelli, J. A., Chow, J., Reisman, S. E., Petrosino, J. F., et al. (2013) · Cell · doi:10.1016/j.cell.2013.11.024 · Cited by 3,283 · cited 8×
“Sci. 2019, 20, 2115 19 of 28 Lactobacillus rhamnosus, Bifidobacterium infantis, Bifidobacterium longus, Lactobacillus helveticus, Lactobacillus reuteri and Lactobacillus paracasei Improvement of GI problems Humans [106] Lactobacillus reuteri - Reversing inflammation caused through lipopolysaccharides - Stimulating the…”
BackgroundInfluentialInteractions between the microbiota, immune and nervous systems in health and disease
Fung, T. C., Olson, C. A., & Hsiao, E. Y. (2017) · Nature Neuroscience · doi:10.1038/nn.4476 · Cited by 1,900
The central nervous system and the gut microbiome
Sharon, G., Sampson, T. R., Geschwind, D. H., & Mazmanian, S. K. (2016) · Cell · doi:10.1016/j.cell.2016.10.027 · Cited by 1,513 · cited 1×
“The microbial composition varies through age, diet, diseases, geography [37,68] and shared environment [34].”
BackgroundGut/brain axis and the microbiota
Mayer, E. A., Tillisch, K., & Gupta, A. (2015) · Journal of Clinical Investigation · doi:10.1172/jci76304 · Cited by 1,503
Kang, D.-W., Adams, J. B., Gregory, A. C., Borody, T., Chittick, L., Fasano, A., Khoruts, A., Geis, E., Maldonado, J., McDonough-Means, S., et al. (2017) · Microbiome · doi:10.1186/s40168-016-0225-7 · Cited by 1,391 · cited 13×
“Especially, faecal microbiota transfers significantly ameliorated ASD behavioural symptoms and GI problems in autistic children [79].”
BackgroundMethodInfluentialHow informative is the mouse for human gut microbiota research?
Nguyen, T. L. A., Vieira-Silva, S., Liston, A., & Raes, J. (2015) · Disease Models & Mechanisms · doi:10.1242/dmm.017400 · Cited by 1,334
Cited by
Items 201–300 of 427
Abnormal Porphyrin Metabolism in Autism Spectrum Disorder and Therapeutic Implications
Indika, N.-L. R., Senarathne, U. D., Malvaso, A., Darshana, D., Owens, S. C., Mansouri, B., Semenova, Y. M., & Bjørklund, G. (2023) · Molecular Neurobiology · doi:10.1007/s12035-023-03722-z · Cited by 13
Yang, T., Zhang, Q., Chen, L., Dai, Y., Jia, F., Hao, Y., Li, L., Zhang, J., Wu, L., Ke, X., et al. (2023) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-023-06122-3 · Cited by 12
“These symptoms affect the core symptoms of ASD and intervention effects and have, therefore become a research hotspot (Srikantha & Mohajeri, 2019).”
Barba-Vila, O., García‐Mieres, H., & Ramos, B. (2024) · Nutrition Reviews · doi:10.1093/nutrit/nuae010 · Cited by 14
Increasing spatial working memory in mice with Akkermansia muciniphila
Ahn, J., Kim, S., Han, E.-J., Hong, S., & Chung, H. (2025) · Communications Biology · doi:10.1038/s42003-025-07975-3 · Cited by 12
“Intriguingly, some research suggests that the gut microbiome might even in fl uence neurological diseases and neuronal functions through the gut-brain axis, pointing to a potential link between the gut microbiome and intelligence 6,8,9,51,52 .”
The role of the microbiota-gut-brain axis in schizophrenia: an immunological perspective
Su, B.-W., Li, Y., Yang, L.-Y., Yang, H., Wang, W., Ren, H., Bao, Y.-N., Lao, J.-Y., & Luan, Z. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1711756 · Cited by 12
“Autism spectrum disorder(ASD) presents with reduced microbial diversity yet increased biomass in pediatric populations (255, 256), featuring a shift from bene fi cial microorganisms toward spore-forming, antibiotic-resistant, and/ or neurotoxin-producing species (257).”
Gut virome plays an extended role with bacteriome in neurological health and disease
Shrivastav, K., Pandey, M., Gor, H., & Nema, V. (2026) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2026.125754 · Cited by 12
ToxPoint: Brain Barrier Systems Play No Small Roles in Toxicant-induced Brain Disorders
Zheng, W., & Ghersi‐Egea, J. (2020) · Toxicological Sciences · doi:10.1093/toxsci/kfaa053 · Cited by 11
Hazan, S., Haroon, J. M., Jordan, S., & Walker, S. J. (2024) · Journal of Medical Cases · doi:10.14740/jmc4209 · Cited by 12
Devason, A. S., Thaiss, C. A., & de la Fuente‐Núñez, C. (2024) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.4c00307 · Cited by 11
Lombardi, M., & Troisi, J. (2021) · Nutrients · doi:10.3390/nu13103492 · Cited by 13
“As a consequence, FMT carries the risk of transmitting infections and transferring pathogens, so a thorough screening of donors is required prior to donation, in order to reduce and prevent the occurrence of adverse events [68,69].”
BackgroundGatea, F., Sârbu, I., & Vamanu, E. (2021) · Microorganisms · doi:10.3390/microorganisms9030590 · Cited by 12
“The gut–brain axis plays an essential role in supporting and controlling physiological functions [3].”
BackgroundGiulio, P. (2021) · Archives of Clinical Gastroenterology · doi:10.17352/2455-2283.000100 · Cited by 12
Tryptophan Metabolism in Neurodevelopment and Its Implications For Neurodevelopmental Disorders
Giuliano, M. G., & Tognini, P. (2025) · Molecular Neurobiology · doi:10.1007/s12035-025-05437-9 · Cited by 14
Conti, M. V., Santero, S., Luzzi, A., & Cena, H. (2023) · Nutrition Research Reviews · doi:10.1017/s0954422423000215 · Cited by 12
“…carbohydrates metabolism, individuals with ASD often exhibit sugar malabsorption, which may be attributed to a decreased expression of disaccharidases, specifically sodium – glucose transporter 1 (SGLT1) and glucose transporter 5 (GLUT5), in the brush border in the intestinal epithelium (25,33) .”
InfluentialOnce upon a Time Oral Microbiota: A Cinderella or a Protagonist in Autism Spectrum Disorder?
Mussap, M., Beretta, P., Esposito, E., & Fanos, V. (2023) · Metabolites · doi:10.3390/metabo13121183 · Cited by 14
“Further metabolic alterations associated with ASD are the upregulation of 3-(3-hydroxyphenyl)-3-hydroxy propionic acid, 3-hydroxyphenyl acetic acid, and 3-hydroxyhippuric acid, indicating perturbations in phenylalanine metabolism [77].”
BackgroundEating disorder in children: Impact on quality of life, with a spotlight on autism spectrum disorder
Smolko, N. A., Ильгамович, В. Р., Kabdesh, I. M., Абдулахатовна, Ф. Р., & Mukhamedshina, Y. O. (2023) · Nutrition Research · doi:10.1016/j.nutres.2023.12.006 · Cited by 12
Salari, Z., Moslemizadeh, A., Tezerji, S. S., Sabet, N., parizi, A. S., Khaksari, M., Sheibani, V., Jafari, E., Shafieipour, S., & Bashiri, H. (2024) · Birth Defects Research · doi:10.1002/bdr2.2310 · Cited by 10
“Human studies have shown that in addition to social deficits, ASD patients suffer from gastrointestinal disorders, and systemic inflammation (Srikantha & Mohajeri, 2019).”
BackgroundInfluentialSpecialized Diet Therapies: Exploration for Improving Behavior in Autism Spectrum Disorder (ASD)
Bjørklund, G., Meguid, N. A., Dadar, M., Pivina, L. M., Kałużna‐Czaplińska, J., Jóźwik-Pruska, J., Aaseth, J., Chartrand, M. S., Waly, M. I., Al-Farsi, Y. M., et al. (2020) · Current Medicinal Chemistry · doi:10.2174/0929867327666200217101908 · Cited by 11
Autism Risk and Perinatal Antibiotic Use
Nitschke, A. S., Karim, J. L., Vallance, B. A., Bickford, C., Ip, A., Lanphear, N. E., Lanphear, B. P., Weikum, W., Oberlander, T. F., & Hanley, G. E. (2022) · PEDIATRICS · doi:10.1542/peds.2022-057346 · Cited by 10
Farias, S. D. S., Montechese, A. C. D., Mufalo, V. C., Sabei, L., Sarmiento, M. P., da Silva, A. N., Ferraz, P. A., Pugliesi, G., Ribeiro, C. V. D. M., Oliveira, C. A. D. A., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1139249 · Cited by 12
Zhang, L., Lai, C., Yanhong, S., Huizhong, G., Li, Y., Zhen, Y., Shan, X., Gong, F., Lv, Y., Li, J., et al. (2022) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2022/4093138 · Cited by 12
Zhang, F., Yang, X., Jiang, Y., Mao, X., Liu, H., Yang, Y., Chen, J., Chen, Z., Li, H., Zhang, X., et al. (2024) · Frontiers in Microbiology · doi:10.3389/fmicb.2024.1331130 · Cited by 9
“Intestinal microorganisms have the capacity to synthesize neurotransmitters, thereby impacting the microbiota-gut-brain axis (Srikantha and Mohajeri, 2019).”
BackgroundRemember the gut: The emerging role of microbial SCFAs in cognitive health
de Paiva, I. H. R., Duarte-Silva, E. P., & Peixoto, C. A. (2025) · Food Bioscience · doi:10.1016/j.fbio.2025.107838 · Cited by 16
Li, J., Lin, W., Yuan, C., Lingling, Z., Qianqian, J., Xu, A., & Yansong, G. (2023) · Life Sciences · doi:10.1016/j.lfs.2023.122330 · Cited by 9
Seeing beyond words: Visualizing autism spectrum disorder biomarker insights
Xie, X., Zhou, R., Fang, Z., Zhang, Y., Wang, Q., & Liu, X. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e30420 · Cited by 9
Multi-Compartment SCFA Quantification in Human
Monteiro, J., Lefèvre, A., Dufour‐Rainfray, D., Oury, A., Chicheri, G., Galineau, L., Blasco, H., Nadal‐Desbarats, L., & Emond, P. (2024) · American Journal of Analytical Chemistry · doi:10.4236/ajac.2024.156012 · Cited by 10
“The modification of SCFA levels was also described in Autism Spectrum Disorders (ASD) [16] [17], Colon Cancer [18], Crohn’s Disease [19] or cardiovascular diseases [20].”
MethodJaureguiberry, S., & Venturino, A. (2020) · International Journal for Vitamin and Nutrition Research · doi:10.1024/0300-9831/a000630 · Cited by 9
Costanza, C., Gallai, B., Sorrentino, M., Gnazzo, M., Pisanò, G., Parisi, L., Germanò, E., Maltese, A., Esposito, M., Roccella, M., et al. (2025) · Medicina · doi:10.3390/medicina61081346 · Cited by 8
“This suggests that gut microbiota might play a role in worsening the symptoms associated with ASD [45].”
Açıkel, S. B., Kara, A., Bağcı, Z., & Can, Ü. (2023) · International Journal of Developmental Neuroscience · doi:10.1002/jdn.10287 · Cited by 8
Mavel, S., Pellé, L., & Andres, C. R. (2025) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2025.101074 · Cited by 9
“Only four non-randomized studies showed improvements in the overall severity of ASD (Srikantha and Mohajeri, 2019).”
Sánchez-Recillas, E., Almanza‐Aguilera, E., Dufoo‐Hurtado, E., Luzardo‐Ocampo, I., Campos-Vega, R., & Vergara‐Castañeda, H. A. (2024) · Journal of Functional Foods · doi:10.1016/j.jff.2024.106063 · Cited by 9
“Although inconclusive, current evidence suggests that increasing SFCAs concentrations helps reduce the pathophysiology of ASD (MacFabe, 2012; Srikantha & Mohajeri, 2019).”
Wu, Y., & Su, Q. (2024) · Nutrients · doi:10.3390/nu16152382 · Cited by 20
“The gut–brain axis, a bidirectional communication network, has been implicated in the development and manifestation of ASD [4,5].”
BackgroundInfluentialAgrawal, S., Rath, C. P., Rao, S. C., Whitehouse, A., & Patole, S. (2025) · Microorganisms · doi:10.3390/microorganisms13030545 · Cited by 9
Cauli, O., Guevara-González, J., Guevara-Campos, J., & González, L. (2021) · Current Clinical Pharmacology · doi:10.2174/2772432816666210805141257 · Cited by 9
Millennium Nutrient N,N-Dimethylglycine (DMG) and its Effectiveness in Autism Spectrum Disorders
Dhanjal, D. S., Bhardwaj, S., Chopra, C., Singh, R., Patočka, J., Plucar, B., Nepovimová, E., Vališ, M., & Kuča, K. (2021) · Current Medicinal Chemistry · doi:10.2174/0929867328666211125091811 · Cited by 11
Lee, Y.-F., Wu, M., Sheng‐Kai, K., Huang, J., & Wei, J. C. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2023.1116239 · Cited by 9
“The “microbiome-gut-brain axis” is known to play an important role in the pathogenesis of neurodevelopmental diseases, such as ASD (24).”
BackgroundGong, X.-R., You, X.-R., Guo, M.-R., Ding, X., & Ma, B. (2023) · Medicine · doi:10.1097/md.0000000000036794 · Cited by 8
“[24] In recent years, research on the mechanism and treatment of ASD has become closely related to studies on gut microbiota, establishing a significant relationship between ASD and gut microbiota.”
BackgroundKim, M., Chung, S., Yang, J.-C., Park, J., Nam, S. H., & Park, T. W. (2020) · Journal of korean Academy of Child and Adolescent Psychiatry · doi:10.5765/jkacap.200013 · Cited by 9
Cho, Y. J., Shin, B., Lee, S., Park, S. M., Kim, Y., Kim, J., & Kim, E. J. (2023) · Microorganisms · doi:10.3390/microorganisms11082063 · Cited by 7
“In one previous study regarding autistic children, many of the metabolite level alterations observed in the blood and urine were found to be of bacterial origin, including short chain fatty acids (SCFAs), indoles, and lipopolysaccharides (LPS) [30].”
BackgroundPharmacotherapy for the core symptoms of autism spectrum disorder
Tan, P., Shen, X., Zeng, L., Weng, X., & Geng, H.-Y. (2024) · Journal of Zhejiang University SCIENCE B · doi:10.1631/jzus.b2300864 · Cited by 7
“These include the excitatory-inhibitory imbalance of glutamate and GABA (Siegel-Ramsay et al., 2021), the gut-brain-axis hypothesis (Srikantha and Mohajeri, 2019), and abnormalities in brain structure and function (Ecker et al., 2015).”
Xiao, H., Zhu, H., Zeng, T.-A., Xu, F., Yu, S.-H., & Yang, C.-J. (2025) · Neuroscience · doi:10.1016/j.neuroscience.2025.01.010 · Cited by 7
Emerging autism and Fragile X syndrome treatments
Parkhill, M., Salmaso, N., D’Angiulli, A., Lee, V., & Aguilar‐Valles, A. (2025) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2025.02.004 · Cited by 7
Azari, H., Morovati, A., Gargari, B. P., & Sarbakhsh, P. (2022) · Review Journal of Autism and Developmental Disorders · doi:10.1007/s40489-022-00348-0 · Cited by 7
“…species can produce Gamma aminobutyric acid (GABA) which is involved in the metabolism of an excitatory neurotransmitter called glutamate that negatively correlates with the severity of behavioral symptoms of ASD (Horder et al., 2018; Iglesias-Vázquez et al., 2020; Srikantha & Mohajeri, 2019).”
Asbjornsdottir, B., Miranda-Ribera, A., Fiorentino, M. R., Konno, T., Çetinbaş, M., Lan, J., Sadreyev, R. I., Gudmundsson, L. S., Gottfreðsson, M., Lauth, B., et al. (2022) · Biomedicines · doi:10.3390/biomedicines11010091 · Cited by 8
“The Ztm female BC group harbored a significantly reduced abundance of Desulfovibrio (an increased abundance is known in BP [220,223], and in ASD [52,211,229,230]), reduced abundance of Blautia (reduced abundance known in PD [210], yet an increased abundance in MDD [205,209,231]) when compared with the Ztm female contr…”
ResultInfluentialOlaguez-Gonzalez, J. M., Schaeffer, S. E., Bretón‐Deval, L., Alfaro-Ponce, M., & Chaírez, I. (2024) · Neural Computing and Applications · doi:10.1007/s00521-024-09458-8 · Cited by 9
“ASD patients exhibit decreased levels of overall SCFAs, with elevated propionate concentrations, suggesting a significant decline in butyrate synthesis [1].”
InfluentialYang, H., Wang, A., Yang, J., Luo, R., & Yang, Y. (2025) · Frontiers in Microbiology · doi:10.3389/fmicb.2025.1650212 · Cited by 6
“Evidence suggests that excess butyrate from specific microbial sources can influence neurodevelopment through epigenetic regulation of gene expression or direct interference with mitochondrial function (Dinan and Cryan, 2017; Srikantha and Mohajeri, 2019).”
Gaougaou, G., Zahra, R., Morel, S., Bélanger, V., Knoth, I. S., Cousineau, D., d’Arc, B. F., Grzywacz, K., Rousseau, G., Déziel, É., et al. (2025) · Journal of Neurodevelopmental Disorders · doi:10.1186/s11689-025-09617-5 · Cited by 6
“Emerging data suggest that gut dysbiosis may be associated to ASD and its symptoms ([48], reviewed in [49]), suggesting a bidirectional communication through the gut-brain axis.”
Santos, J. X., Rasga, C., & Vicente, A. M. (2021) · IntechOpen eBooks · doi:10.5772/intechopen.95758 · Cited by 8
Role of oxidative stress in the pathogenesis of autism spectrum disorders
Belokoskova, S. G., & Tsikunov, S. G. (2023) · Reviews on Clinical Pharmacology and Drug Therapy · doi:10.17816/rcf567781 · Cited by 6
Metabolomics – an overview. From basic principles to potential biomarkers (part 2)
Dufour-Rainfray, D., Lambérioux, M., Boulard, P., Guidotti, M., Delaye, J.-B., Ribeiro, M.-J., Gauchez, A., Balageas, A.-C., Emond, P., & Agin, A. (2020) · Médecine Nucléaire · doi:10.1016/j.mednuc.2020.02.004 · Cited by 10
Therapeutic dietary approach to children with autistic spectrum disorder
Torres, F. C. I., Medina, A. C. D. G., Toribio, S. L. G., Guevara, K. K. J., Risco, K. B. L., & Huamán-Saavedra, J. J. (2022) · Revista de la Facultad de Medicina Humana · doi:10.25176/rfmh.v22i4.4729 · Cited by 7
Gastrointestinal Tract Symptomatology in Adults with Pica and Autism
Alexander, D. D., Lunde, S. E., & Berger, D. E. (2020) · Autism and Developmental Disorders · doi:10.17759/autdd.2020180401 · Cited by 7
“The critical “gut-behavior axis” involves neural, hormonal, immune, and metabolic pathways [3; 42].”
BackgroundThe Contribution of the Gut-Brain-Microbiota Axis to Brain Health Throughout the Lifespan
Qansuwa, E. M., Atalah, H. N., Abdelkader, M. S., Russell, A. E., Dakhlallah, D. A., & Brown, C. M. (2024) · Springer eBooks · doi:10.1007/978-981-99-7557-0_2 · Cited by 6
Day, A. W., Hayes, E., Perez-Lozada, J., DiLeo, A., Blandino, K. L., Maguire, J. L., & Kumamoto, C. A. (2025) · mBio · doi:10.1128/mbio.02239-25 · Cited by 5
Yang, T., He, Y., Huang, M., Liu, Y., Liu, F., Li, Y., Gao, S., Shen, L., Xu, Q., & Yu, C. (2025) · Acupuncture and Herbal Medicine · doi:10.1097/hm9.0000000000000174 · Cited by 5
Luyens, B., Felgueroso-Bueno, F., Everard, A., & Massat, I. (2026) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2026.01.038 · Cited by 5
Dehkordi, Z. V., Ghadiri, M., Jivad, N., & Amini-Khoei, H. (2026) · The World Journal of Biological Psychiatry · doi:10.1080/15622975.2026.2677901 · Cited by 5
“Evidence have reported that gene expression of CLDN-5 and CLDN-12 increased in the brain of patients with autism, although protein level of CLDN-12 significantly reduced (Fiorentino et al., 2016; Srikantha and Mohajeri, 2019).”
Al-Dossari, A. M., Al‐Harbi, L. N., Al-Otaibi, N. M., Almubarak, A., Almnaizel, A. T., Alshammari, G. M., Shamlan, G. H., Alshatwi, A. A., & El-Ansary, A. K. (2023) · Metabolites · doi:10.3390/metabo13040497 · Cited by 5
“In the current study, the level of TBARS, as an oxidative stress biomarker, was much lower in VPA GM-treated rats in both brain homogenate and serum, which supports our hypothesis and agrees with the results of previous studies regarding the possible role of the microbiota–gut–brain axis in autism spectrum disorder [5…”
ResultEnteric Dysbiosis in Children With Autism Spectrum Disorder and Associated Response to Stress
Cavanaugh, G., Bai, J., Tartar, J. L., Lin, J., Nunn, T., Sangwan, N., Patel, D., Stanis, S., Patel, R. K., Rrukiqi, D., et al. (2024) · Cureus · doi:10.7759/cureus.53305 · Cited by 6
“Further, studies have identified enteric dysbiosis in children with ASD as a characteristic of the disorder, suggesting that the gut-brain axis (GBA) may play a role in the onset of ASD [8,9].”
BackgroundRole of Gut Microbiota in Neuroinflammation and Neurological Disorders
Raj, K., Arora, N., Rohit, B. S. P., Awasthi, A., Patel, M., Chaudhary, A., Singh, S., & Gupta, G. D. (2024) · Frontiers in clinical drug research. CNS and neurological disorders · doi:10.2174/9789815179842124120005 · Cited by 5
Vashisht, A., Vashisht, V., Singh, H., Ahluwalia, P. K., Mondal, A. K., Williams, C., Farmaha, J. K., Woodall, J., & Kolhe, R. B. (2024) · Viruses · doi:10.3390/v16081183 · Cited by 7
“Inflammation-induced bacterial leakage from the gastrointestinal system may transport bacteria and metabolites into the brain parenchyma, causing CNS disease [79].”
BackgroundChamtouri, M., Merghni, A., Miranda-Cadena, K., Sakly, N., Gaddour, N., Reyes‐Gavilán, C. G. D. L., Mastouri, M., Eraso, E., & Quindós, G. (2024) · Journal of Fungi · doi:10.3390/jof10110730 · Cited by 7
“Candida colonization can cause malabsorption of carbohydrates and minerals, and can release ammonia and toxins, which have been reported to be associated with some autistic behaviour [16,17].”
Beyond the Gut Feeling: Machine-Learning Methods for Autism Screening
Zhusubalieva, A., & Oudah, M. (2024) · IEEE International Conference on Bioinformatics and Bioengineering (BIBE) · doi:10.1109/bibe63649.2024.10820459 · Cited by 5
Cavenaghi, A., Mallah, N. E. Z., Navarro, L., Group Sensogenomics Working, Martinón-Torres, F., Gómez‐Carballa, A., & Salas, A. (2025) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2025.1696704 · Cited by 6
Kacimi, F. E., Ed-Day, S., Didou, L., Azzaoui, F.-Z., Ramchoun, M., Arfaoui, A., & Boulbaroud, S. (2023) · Journal of Dietary Supplements · doi:10.1080/19390211.2023.2179154 · Cited by 6
Szablewski, L. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-819265-8.00065-6 · Cited by 5
Alshehri, S., Nadeem, A., Ahmad, S. F., Alqarni, S. S., Al-Harbi, N. O., AL-Ayadhi, L. Y., Attia, S. M., Alqarni, S. A., & Bakheet, S. A. (2023) · Metabolites · doi:10.3390/metabo13020286 · Cited by 6
“As a result, bacterial products with a potential to activate TLR4 on T cells have been identified in the systemic circulation of ASD subjects [41,42].”
BackgroundXu, X., Zhang, Y., & Zhang, X. (2023) · Iranian Journal of Psychiatry and Behavioral Sciences · doi:10.5812/ijpbs-126508 · Cited by 5
“Many studies have shown a significant relationship between intestinal bacteria and autism spectrum disorder (ASD) (1, 2).”
BackgroundKumar, M., Mehan, S., Sharma, T., Kumar, A., Khan, Z., Sharma, A. K., Gupta, G. D., & Kumar, N. (2025) · Endocrine Metabolic & Immune Disorders - Drug Targets · doi:10.2174/0118715303369166250325110016 · Cited by 4
Esvap, E., & Ülgen, K. Ö. (2025) · Biotechnology Journal · doi:10.1002/biot.70164 · Cited by 4
“Consequently, dietary and microbial interventions have been investigated as potential modulators of neurological outcomes [6].”
Chang, J.-C., Chen, Y.-C. D., Lin, H.-T., Chen, Y., & Gau, S. S. (2025) · Translational Psychiatry · doi:10.1038/s41398-025-03768-8 · Cited by 4
Castro-Martínez, J. A., Vargas, E., Díaz-Beltrán, L., & Esteban, F. J. (2024) · Current Issues in Molecular Biology · doi:10.3390/cimb46120812 · Cited by 4
“Some body systems are also affected, such as digestive [4,5], immune [6–9], circulatory [10,11] and nervous [12–14].”
He, Y., He, Y., & Cheng, B. (2025) · Pharmacogenomics and Personalized Medicine · doi:10.2147/pgpm.s494126 · Cited by 6
Duque, L. M. S., Trejos-Gallego, D. M., Triviño-Valencia, J., Buitrago, M. V., Meñaca-Puentes, M. A., Villa, C. A. R., Orjuela-Rodríguez, M., & Galvis, C. A. N. (2026) · Retos · doi:10.47197/retos.v74.117914 · Cited by 4
O’Brien, K., & Blair, P. (2021) · Springer eBooks · doi:10.1007/978-3-030-78559-8_10 · Cited by 4
Suleymanova, Z. Y., Ustinova, N. V., & Turti, T. V. (2022) · Педиатрическая фармакология · doi:10.15690/pf.v19i2.2397 · Cited by 5
Neurodevelopmental Disorders of the Cerebellum: Autism Spectrum Disorder
Toback, M., Rad, A. A., Okafor, I. A., Allahtavakoli, M., Zangeneh, K., Siddiqui, T. J., & Marzban, H. (2023) · Contemporary clinical neuroscience · doi:10.1007/978-3-031-23104-9_21 · Cited by 4
Doğan, H. E., Işık, Ü., Büyükbayram, H. İ., & Arıcan, H. M. (2024) · International Journal of Developmental Disabilities · doi:10.1080/20473869.2023.2298563 · Cited by 8
“In this context, intestinal and blood-brain barrier (BBB) permeability has been of interest in the etiology of ASD (Srikantha and Hasan Mohajeri 2019).”
Malnutrition-Induced Oxidative Stress in Nervous System and Its Health Implications
Veleri, S. (2023) · Springer eBooks · doi:10.1007/978-981-99-7652-2_17 · Cited by 6
Premature Infant Gut Microbiome relationships with childhood behavioral scales: preliminary insights
Dutra, S. V. O., Sarkar, A., Yoo, J. Y., Shaffer‐Hudkins, E., & Groer, M. E. (2024) · Frontiers in Nutrition · doi:10.3389/fnut.2023.1294549 · Cited by 4
Neurodevelopmental and Neuropsychiatric Disorders
Traetta, M. E., Filho, A. M. C., Akinluyi, E. T., & Tremblay, M. (2024) · Advances in neurobiology · doi:10.1007/978-3-031-55529-9_26 · Cited by 4
Jain, A., Dhir, N., Prabha, P. K., Raja, A., Sharma, A. R., Kaundal, T., Charan, S., Bhatia, A., Banerjee, D., Saikia, B., et al. (2025) · Journal of Neuroscience Research · doi:10.1002/jnr.70049 · Cited by 4
“Some studies have reported gut- brain-axis impairment and autism-like symptoms with CREB signaling dysregulation (Mahmoud et al. 2024; Srikantha and Mohajeri 2019).”
Medical management, prevention and mitigation of environmental risks factors in Neurology
Reis, J. J., Román, G. C., Giroud, M., Palmer, V. S., & Spencer, P. S. (2019) · Revue Neurologique · doi:10.1016/j.neurol.2019.10.001 · Cited by 4
Sunand, K., Mohan, G. K., & Bakshi, V. (2021) · International Journal of Applied Pharmaceutical Sciences and Research · doi:10.21477/ijapsr.6.3.02 · Cited by 5
Aldegheri, L., Kharrat, F., Conti, A., Monica, F., Busa, F., Campisciano, G., Zanotta, N., Cason, C., & Comar, M. (2024) · Microorganisms · doi:10.3390/microorganisms12081625 · Cited by 6
“For example, lipopolysaccharides (LPSs), which are the en-dotoxins of Gram-negative bacteria, can pass through the damaged intestinal barrier to the brain and induce a proinflammatory environment, potentially leading to pathological [45,46].”
BackgroundLami, K. F., de Oliveira, V. F., & Batista, K. Z. S. (2021) · Research Society and Development · doi:10.33448/rsd-v10i4.14185 · Cited by 5
Lin, J., Liu, G., Han, Z., Qiang, G., Wang, Z., Chang, Z., Gao, Y., & Ma, D. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.11.05.370528 · Cited by 5
Zheng, Y., Yu, Y., Chen, M., Zhang, H., Wang, W., Fan, X., Sun, L., Tang, L., & Ta, D. (2025) · Molecular Neurobiology · doi:10.1007/s12035-025-04709-8 · Cited by 3
Téglás, T., Torices, S., Marcos, A. C., Orzechowska-Wylęgała, B., & Toborek, M. J. (2025) · Fluids and Barriers of the CNS · doi:10.1186/s12987-025-00669-2 · Cited by 3
Fundora, M. P., Dressner, L., Calamaro, C., Brown, A., John, A. S., Keiffer, R., Alexander, N., Huang, H., Gillespie, S. E., Denning, P. W., et al. (2025) · Journal of Parenteral and Enteral Nutrition · doi:10.1002/jpen.70038 · Cited by 3
“30 In congenital heart disease, lower Bifidobacterium and Lactobacillus were found in mothers of infants with congenital heart disease as well as increased lipopolysaccharide, a pro ‐ inflammatory mediator, further suggesting a role for Bifidobacterium in congenital heart disease.”
Queiroz, S. A. L., Guimaraes, D. O., Ferreira, L. A., Martinelli, L., Werly, R. M. M., Amorim, R. F., Holzbach, L. B. S. S., Badaró, R. J. S., Santos, A. A. B., Vasquez, E. C., et al. (2026) · BMC Pediatrics · doi:10.1186/s12887-026-06515-0 · Cited by 5
“Within this broader context, the present trial offers evidence of coherent behavioral signals using validated ASD-specific instruments over a 90-day intervention period, which is longer than many previous studies [5, 6, 27].”
Influential articles in autism and gut microbiota: bibliometric profile and research trends
Ying, J., Zhang, M. W., Wei, K., Wong, S. H., & Subramaniam, M. (2025) · Frontiers in Microbiology · doi:10.3389/fmicb.2024.1401597 · Cited by 3
Berbé, L., Machouart, M., Luc, A., Albuisson, É., Strazielle, C., & Bisson, C. (2025) · Frontiers in Microbiology · doi:10.3389/fmicb.2025.1552656 · Cited by 7
“…ASD often have intestinal and immune system disorders that can lead to chronic inflammation in which periodontal bacteria could potentially play a role, similar to the established link between gut microbiota dysbiosis and ASD, and ultimately influence their behavior (Srikantha and Mohajeri, 2019).”
Gut Microbiota and Gut-Brain Axis in Health and Disease A Narrative Review
Wasiak, J., Zielonka, K., Dądela, B., Markowski, M., Śliwa, N., Majewska, E. M., Kawalska, E., Gnitecki, S., Janczura, S., & Borowski, M. (2025) · Quality in Sport · doi:10.12775/qs.2025.41.60102 · Cited by 3
“SCFAs are able to cross the BBB and impact early brain development by influencing the production of neurotransmitters like serotonin and dopamine (Srikantha & Mohajeri, 2019) .”
de Diego‐Otero, Y., Bodoque-García, A., Quintero-Navarro, C., Medina, R. C., & Salgado-Cacho, J. M. (2025) · Psychiatry International · doi:10.3390/psychiatryint6030107 · Cited by 4
“…have shown that children with more severe gastrointestinal issues tend to exhibit higher levels of aggression and significant sleep disturbances compared to those with ASD, but without notable gut problems, highlighting the potential role of gut microbiota in exacerbating ASD symptomatology [19].”
Liao, X., Long, J., Wang, X., Han, K., Tang, Z., Chen, J., Zhang, Y., & Zhang, H. (2025) · AMB Express · doi:10.1186/s13568-025-01969-4 · Cited by 5
“…infection”: excessive proliferation of intestinal pathogens has been shown to directly damage the intestinal mucosal barrier and to release pro-inflammatory substances such as lipopolysac-charides into the circulatory system via the “leaky gut-inflammation” pathway (Srikantha and Mohajeri 2019).”
Yu, R., Zhang, M., Ahmed, T., Wu, Z., Lv, L., Zhou, G., & Li, B. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph192417020 · Cited by 3
Gonçalves, T. G., Guimarães, J. Q., Terra, L. S., Padovan, A. C. B., & Cardoso, E. J. R. (2023) · Arquivos de Ciências da Saúde da UNIPAR · doi:10.25110/arqsaude.v27i5.2023-077 · Cited by 4
The Brain-Gut Axis in Alzheimer’s Disease
Patel, M. (2023) · Advances in Alzheimer s Disease · doi:10.4236/aad.2023.123003 · Cited by 3
Lam, E. W., & Ip, B. P. (2024) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.2897 · Cited by 3
Metadata
- Authors
- Srikantha, P., & Mohajeri, M. H.
- Affiliations
- University of Zurich (CH)
- Corresponding author
- Mohajeri, M. Hasan
- ORCID
- Mohajeri, M. Hasan
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2019-04-29
- Volume
- 20
- Issue
- 9
- Pages
- 2115
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC6539237
- OpenAlex
- W2943088522
- Cited by
- 400
- References
- 137
- Citations by year
- 2026: 32 · 2025: 68 · 2024: 60 · 2023: 64 · 2022: 67 · 2021: 56 · 2020: 42 · 2019: 11
- FWCI
- 3.87
- Type
- journal article
- Language
- en
- Open access
- gold
- dx.doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Life Sciences › Neuroscience › Cognitive Neuroscience › Autism Spectrum Disorder Research
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Keywords
- autism spectrum disorder, gut microbiota, microbiota-gut-brain axis, dysbiosis, gastrointestinal symptoms, bacterial metabolites, short-chain fatty acids, indole, lipopolysaccharide, leaky gut, blood-brain barrier, mitochondrial dysfunction, oxidative stress, probiotics, phenylalanine metabolism, biomarkers
- MeSH terms
- Autism Spectrum Disorder, Gastrointestinal Microbiome, Animals, Brain, Child, Humans, Intestinal Mucosa, Intestines, Mitochondria, Risk Factors, Comorbidity, Probiotics, Biodiversity, Metabolic Networks and Pathways, Metabolomics, Prebiotics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.